Trials / Completed
CompletedNCT04612036
In Vivo Kinematics for Subjects With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA
Multi-center In Vivo Kinematics for Subjects Implanted With Smith & Nephew Journey II BCS TKA, Journey II CR TKA, Or Journey II XR TKA
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- The University of Tennessee, Knoxville · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs.
Detailed description
The objective of this study is to determine and compare the in vivo kinematics and vibroarthrography (VAG) signals for subjects implanted with Journey II Bi-Cruciate Stabilized (BCS), CR (Cruciate Retaining), and Bi-Cruciate Retaining (XR) TKAs. The Journey II BCS Knee System was designed to resect and replicate both the PCL and ACL, the Journey II CR System retains the posterior cruciate ligament, while the Journey II XR System retains the cruciate and collateral ligaments so they remain intact.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Journey II Bi-Cruciate Stabilized TKA | Total Knee Arthroplasty System |
| DEVICE | Journey II Cruciate Retaining TKA | Total Knee Arthroplasty System |
| DEVICE | Journey II Bi-Cruciate Retaining TKA | Total Knee Arthroplasty System |
Timeline
- Start date
- 2020-10-22
- Primary completion
- 2022-05-16
- Completion
- 2022-05-16
- First posted
- 2020-11-02
- Last updated
- 2023-11-29
- Results posted
- 2023-11-29
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04612036. Inclusion in this directory is not an endorsement.